In Part 3 of our 4-part series on GERD and Barrett’s Esophagus, we’re joined by Dr. Caitlin Houghton, a foregut surgeon with Keck Medicine of USC, to discuss what happens after Barrett’s Esophagus is diagnosed—and how patients can reduce their cancer risk and manage the condition effectively.

From reflux control to endoscopic eradication therapy (EET), and in some cases, surgery, Dr. Houghton breaks down the latest treatment strategies and what patients need to know. This episode offers practical advice, expert insights, and real hope for those navigating life with Barrett’s.

Topics include:

• What Barrett’s Esophagus is and why it matters
  
  

• How doctors decide when and how to treat
  
  

• The role of EET, medications, and lifestyle changes
  
  

• When surgery may be necessary
  
  

• Tips for patients to advocate for their care
  
  

Missed the earlier episodes? Catch up here:
Part 1 – From Reflux to Risk: How Heartburn and GERD Could Lead to Esophageal Cancer
https://gastrogirl.com/podcast/from-reflux-to-risk-how-heartburn-and-gerd-could-lead-to-esophageal-cancer/

Part 2 – Barrett’s Esophagus: The Hidden Risk of Chronic Heartburn
https://gastrogirl.com/podcast/barretts-esophagus-the-hidden-risk-of-chronic-heartburn/

This series is sponsored by Castle Biosciences and produced in collaboration with leading clinicians and researchers committed to improving patient outcomes.

In part 2 of our 4-part series on GERD and Barrett’s Esophagus, we take a closer look at what Barrett’s esophagus is, how it develops from chronic acid reflux, and why early detection is essential to reducing the risk of esophageal cancer.

We’re joined by Dr. Raman Muthusamy, a nationally recognized expert in gastroenterology and advanced endoscopy, who explains how Barrett’s is diagnosed, the latest tools and technologies involved, and how a team-based approach improves outcomes.

If you or someone you care about struggles with long-term heartburn or GERD, this episode offers critical insights to help you take action before it becomes something more serious.

Missed Part 1? Listen or watch now:
From Reflux to Risk: How Heartburn and GERD Could Lead to Esophageal Cancer
https://bit.ly/3Fvzf4o

This series is sponsored by Castle Biosciences and produced in collaboration with leading clinicians and researchers dedicated to improving patient care and outcomes.

Is your heartburn more dangerous than you think?

In this first episode of our 4-part patient-focused series, we break down the serious risks of untreated acid reflux and gastroesophageal reflux disease (GERD)—including its connection to Barrett’s esophagus, the only known precursor to esophageal cancer.

Dr. Dan Lister, a leading Foregut Surgeon and founder of the Arkansas Heartburn Treatment Center, joins us to explain:

• How GERD can progress silently over time

• Why Barrett’s esophagus matters—and how it’s detected

• What red flags to look out for (including when reflux suddenly disappears)

• The latest treatment options that could help prevent cancer

Whether you’ve been living with reflux for years or are newly diagnosed, this episode is packed with life-saving insights.

This special 4-part series is sponsored by Castle Biosciences and produced in collaboration with leading clinicians and researchers dedicated to improving patient outcomes.